308 related articles for article (PubMed ID: 29065378)
1. Clinical relevance of molecular diagnostics in gastrointestinal (GI) cancer: European Society of Digestive Oncology (ESDO) expert discussion and recommendations from the 17th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona.
Baraniskin A; Van Laethem JL; Wyrwicz L; Guller U; Wasan HS; Matysiak-Budnik T; Gruenberger T; Ducreux M; Carneiro F; Van Cutsem E; Seufferlein T; Schmiegel W
Eur J Cancer; 2017 Nov; 86():305-317. PubMed ID: 29065378
[TBL] [Abstract][Full Text] [Related]
2. The multidisciplinary management of gastro-oesophageal junction tumours: European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona.
Van Laethem JL; Carneiro F; Ducreux M; Messman H; Lordick F; Ilson DH; Allum WH; Haustermans K; Lepage C; Matysiak-Budnik T; Cats A; Schmiegel W; Cervantes A; Van Cutsem E; Rougier P; Seufferlein T
Dig Liver Dis; 2016 Nov; 48(11):1283-1289. PubMed ID: 27590840
[TBL] [Abstract][Full Text] [Related]
3. Screening and surveillance in hereditary gastrointestinal cancers: Recommendations from the European Society of Digestive Oncology (ESDO) expert discussion at the 20th European Society for Medical Oncology (ESMO)/World Congress on Gastrointestinal Cancer, Barcelona, June 2018.
Vangala DB; Cauchin E; Balmaña J; Wyrwicz L; van Cutsem E; Güller U; Castells A; Carneiro F; Hammel P; Ducreux M; van Laethem JL; Matysiak-Budnik T; Schmiegel W
Eur J Cancer; 2018 Nov; 104():91-103. PubMed ID: 30342310
[TBL] [Abstract][Full Text] [Related]
4. The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010.
Van Cutsem E; Dicato M; Geva R; Arber N; Bang Y; Benson A; Cervantes A; Diaz-Rubio E; Ducreux M; Glynne-Jones R; Grothey A; Haller D; Haustermans K; Kerr D; Nordlinger B; Marshall J; Minsky BD; Kang YK; Labianca R; Lordick F; Ohtsu A; Pavlidis N; Roth A; Rougier P; Schmoll HJ; Sobrero A; Tabernero J; Van de Velde C; Zalcberg J
Ann Oncol; 2011 Jun; 22 Suppl 5():v1-9. PubMed ID: 21633049
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers for personalized medicine in GI cancers.
Zhang SY; Zhang SQ; Nagaraju GP; El-Rayes BF
Mol Aspects Med; 2015 Nov; 45():14-27. PubMed ID: 26054566
[TBL] [Abstract][Full Text] [Related]
6. Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update.
Cong WM; Bu H; Chen J; Dong H; Zhu YY; Feng LH; Chen J;
World J Gastroenterol; 2016 Nov; 22(42):9279-9287. PubMed ID: 27895416
[TBL] [Abstract][Full Text] [Related]
7. Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Loaiza-Bonilla A; Benson AB; Grothey A; Karimi M; Klempner SJ; Lin D; Mahtani R; Soares HP
Oncologist; 2021 Aug; 26(8):651-659. PubMed ID: 33650740
[TBL] [Abstract][Full Text] [Related]
8. Establishing the Evidence Bar for Molecular Diagnostics in Personalised Cancer Care.
Schneider D; Bianchini G; Horgan D; Michiels S; Witjes W; Hills R; Plun-Favreau J; Brand A; Lawler M;
Public Health Genomics; 2015; 18(6):349-58. PubMed ID: 26571110
[TBL] [Abstract][Full Text] [Related]
9. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
[TBL] [Abstract][Full Text] [Related]
10. Biological implications and clinical value of mir-210 in gastrointestinal cancer.
Yang W; Ma J; Zhou W; Zhou X; Cao B; Fan D; Hong L
Expert Rev Gastroenterol Hepatol; 2017 Jun; 11(6):539-548. PubMed ID: 28317401
[TBL] [Abstract][Full Text] [Related]
11. Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer.
Keller RB; Mazor T; Sholl L; Aguirre AJ; Singh H; Sethi N; Bass A; Nagaraja AK; Brais LK; Hill E; Hennessey C; Cusick M; Del Vecchio Fitz C; Zwiesler Z; Siegel E; Ovalle A; Trukhanov P; Hansel J; Shapiro GI; Abrams TA; Biller LH; Chan JA; Cleary JM; Corsello SM; Enzinger AC; Enzinger PC; Mayer RJ; McCleary NJ; Meyerhardt JA; Ng K; Patel AK; Perez KJ; Rahma OE; Rubinson DA; Wisch JS; Yurgelun MB; Hassett MJ; MacConaill L; Schrag D; Cerami E; Wolpin BM; Nowak JA; Giannakis M
JCO Precis Oncol; 2023 Jan; 7():e2200342. PubMed ID: 36634297
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal cancers in the era of theranostics: Updates and future perspectives.
Ghosn M; Kourie HR; Tabchi S
World J Gastroenterol; 2015 Jul; 21(28):8473-7. PubMed ID: 26229391
[TBL] [Abstract][Full Text] [Related]
13. Precision medicine beyond medical oncology: using molecular analysis to guide treatments of colorectal neoplasia.
Molloy MP; Engel A
Expert Rev Gastroenterol Hepatol; 2018 Dec; 12(12):1179-1181. PubMed ID: 30791786
[No Abstract] [Full Text] [Related]
14. Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty.
Lordick F; Obermannova R; Vola D; Douillard JY; Mcgregor K; Van Cutsem E; Tabernero J; Ciardiello F; Cervantes A
ESMO Open; 2019; 4(3):e000533. PubMed ID: 31354964
[TBL] [Abstract][Full Text] [Related]
15. Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel.
Goel A
Future Oncol; 2017 Dec; 13(28):2511-2514. PubMed ID: 29168653
[TBL] [Abstract][Full Text] [Related]
16. EURECCA colorectal: multidisciplinary mission statement on better care for patients with colon and rectal cancer in Europe.
van de Velde CJ; Aristei C; Boelens PG; Beets-Tan RG; Blomqvist L; Borras JM; van den Broek CB; Brown G; Coebergh JW; Cutsem EV; Espin E; Gore-Booth J; Glimelius B; Haustermans K; Henning G; Iversen LH; Han van Krieken J; Marijnen CA; Mroczkowski P; Nagtegaal I; Naredi P; Ortiz H; Påhlman L; Quirke P; Rödel C; Roth A; Rutten HJ; Schmoll HJ; Smith J; Tanis PJ; Taylor C; Wibe A; Gambacorta MA; Meldolesi E; Wiggers T; Cervantes A; Valentini V;
Eur J Cancer; 2013 Sep; 49(13):2784-90. PubMed ID: 23769991
[TBL] [Abstract][Full Text] [Related]
17. Molecular profiles in foregut oncology.
Sukharamwala P; Hennessey D; Wood T; Singh S; Ryan C; Rosemurgy A
Cancer Genet; 2016 Dec; 209(12):537-553. PubMed ID: 27887938
[TBL] [Abstract][Full Text] [Related]
18. Application of Molecular Pathology in Endocrine Pathology.
Linke ES; Tezel GG
Turk Patoloji Derg; 2015; 31 Suppl 1():181-8. PubMed ID: 26177327
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing of DNA damage response genes and gastrointestinal cancers.
Rahmutulla B; Matsushita K; Nomura F
World J Gastroenterol; 2014 Dec; 20(46):17305-13. PubMed ID: 25516641
[TBL] [Abstract][Full Text] [Related]
20. Targeting dynamics of subclones of GI, liver and pancreatic cancers.
Ziogas DE; Glantzounis G; Liakakos T; Roukos DH
Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):773-6. PubMed ID: 27143511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
